<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01564667</url>
  </required_header>
  <id_info>
    <org_study_id>11-16311</org_study_id>
    <nct_id>NCT01564667</nct_id>
  </id_info>
  <brief_title>Attention Bias Modification Treatment for Warzone-Related Posttraumatic Stress Disorder (PTSD)</brief_title>
  <official_title>Attention Bias Modification Treatment for Warzone-Related PTSD: A Randomized Clinical Trial Magnetoencephalography Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Creighton University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>At Ease USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Creighton University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Veterans with Posttraumatic Stress Disorder (PTSD) will be randomly assigned to either
      Attention Bias Modification Treatment (ABMT) designed to reduce bias toward threat or a
      placebo control condition not designed to change attention patterns. Outcome measures will be
      PTSD, anxiety, depression, and alexithymia symptoms as measured by standard psychological
      interviews and questionnaires. Participants will also be invited to participate in
      physiological testing before and after receiving AMBT or placebo to serve as additional
      outcome measures and assess brain functioning, heart rate, and muscle tension.

      The investigators expect to see significant PTSD symptom reduction in the Attention Bias
      Modification Treatment (ABMT) group relative to the placebo control group in which no
      symptomatic relief is expected. At the end of the study, if ABMT is shown to be effective, we
      will offer active ABMT to those participants randomly assigned to the placebo arm if they
      would like to receive the treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Will Posttraumatic Stress Disorder and Symptom decrease with intervention</measure>
    <time_frame>8 weeks</time_frame>
    <description>Using Clinician-Administered PTSD Scale (CAPS): The clinician-Administered PTSD Scale (CAPS) is a 30-item structured interview that corresponds to the DSM-IV criteria for PTSD (Blake, Weathers, Nagy, Kaloupek, Charney, &amp; Keane, 1995) to assess symptoms of PTSD outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Other psychiatics symptoms (ie Depression, Anger, Anxiety)</measure>
    <time_frame>8 weeks</time_frame>
    <description>To assess potential decrease in psychiatric symptoms associated with PTSD, by comparing pre intervention and post intervention scores on psychological measures of deprssion, anger and anxiety.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Posttraumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>Attention Bias Modification Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Attention bias modification training using a computerized spatial attention task (dot-probe) designed to alter threat-bias attention patterns away from threat.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Attentional Control Training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Attention control training using a computerized spatial attention taks (dot-probe) counter balances training toward and away from threat.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Attention Bias Modification Training Protocol</intervention_name>
    <description>Attention Bias Modification computerized training sessions administered 2 times per week for 4 weeks making a total of 8 training sessions.</description>
    <arm_group_label>Attention Bias Modification Treatment</arm_group_label>
    <arm_group_label>Attentional Control Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Veterans with Posttraumatic Stress Disorder (PTSD) serving in United States Military
             after March 20, 2003.

        Exclusion Criteria:

          -  Schizophrenia

          -  Bipolar Disorder

          -  Obsessive Compulsive Disorder

          -  Head Injury with Loss of Consciousness for more than 30 minutes

          -  Active Alcohol/Substance Dependence in past 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amy S Badura Brack, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Creighton University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Creighton University</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68178</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hakamata Y, Lissek S, Bar-Haim Y, Britton JC, Fox NA, Leibenluft E, Ernst M, Pine DS. Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. Biol Psychiatry. 2010 Dec 1;68(11):982-90. doi: 10.1016/j.biopsych.2010.07.021. Erratum in: Biol Psychiatry. 2012 Sep 1;72(5):429.</citation>
    <PMID>20887977</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2012</study_first_submitted>
  <study_first_submitted_qc>March 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2012</study_first_posted>
  <last_update_submitted>January 13, 2016</last_update_submitted>
  <last_update_submitted_qc>January 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PTSD</keyword>
  <keyword>Posttraumatic Stress</keyword>
  <keyword>Post Traumatic Stress</keyword>
  <keyword>Attention Bias</keyword>
  <keyword>Threat Bias</keyword>
  <keyword>Combat</keyword>
  <keyword>Warzone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

